|
US112966A
(en)
*
|
|
1871-03-21 |
|
Improvement in hay and cotton-presses |
|
US3817978A
(en)
|
1971-06-16 |
1974-06-18 |
Syntex Inc |
4-fluoro nucleosides and sugar intermediates, and methods of preparing
|
|
US3852267A
(en)
|
1972-08-04 |
1974-12-03 |
Icn Pharmaceuticals |
Phosphoramidates of 3{40 ,5{40 -cyclic purine nucleotides
|
|
DE3239986A1
(de)
|
1982-10-28 |
1984-05-03 |
Robert Bosch Gmbh, 7000 Stuttgart |
Handwerkzeugmaschine mit einem kreisscheibenfoermigen werkzeug
|
|
US4713383A
(en)
|
1984-10-01 |
1987-12-15 |
Ciba-Geigy Corporation |
Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
|
|
US5679342A
(en)
|
1987-11-18 |
1997-10-21 |
Chiron Corporation |
Hepatitis C virus infected cell systems
|
|
US5712088A
(en)
|
1987-11-18 |
1998-01-27 |
Chiron Corporation |
Methods for detecting Hepatitis C virus using polynucleotides specific for same
|
|
US5714596A
(en)
|
1987-11-18 |
1998-02-03 |
Chiron Corporation |
NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
|
|
US5698390A
(en)
|
1987-11-18 |
1997-12-16 |
Chiron Corporation |
Hepatitis C immunoassays
|
|
US6171782B1
(en)
|
1987-11-18 |
2001-01-09 |
Chiron Corporation |
Antibody compositions to HCV and uses thereof
|
|
IN167775B
(enExample)
|
1988-06-24 |
1990-12-22 |
Hoechst India |
|
|
US6027729A
(en)
|
1989-04-20 |
2000-02-22 |
Chiron Corporation |
NANBV Diagnostics and vaccines
|
|
DE3932052A1
(de)
|
1989-09-26 |
1991-04-04 |
Basf Ag |
Oxazol- bzw. thiazolcarbonsaeureamide
|
|
MY106399A
(en)
|
1990-07-24 |
1995-05-30 |
Pfizer |
Cephalosporins and homologeus, preparation and pharmaceutical composition
|
|
US5432272A
(en)
|
1990-10-09 |
1995-07-11 |
Benner; Steven A. |
Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
|
|
JP2889408B2
(ja)
|
1991-09-17 |
1999-05-10 |
富士写真フイルム株式会社 |
アゾメチン化合物及びこれを含有する熱転写色素供与材料
|
|
GB9202791D0
(en)
|
1992-02-11 |
1992-03-25 |
British Bio Technology |
Compounds
|
|
AU729657B2
(en)
|
1992-05-11 |
2001-02-08 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for inhibiting viral replication
|
|
DE4232852A1
(de)
|
1992-09-30 |
1994-03-31 |
Bayer Ag |
Imidazolinyl-pyridazine
|
|
ZA943999B
(en)
|
1993-06-09 |
1995-02-03 |
Lonza Ag |
Quaternary ammonium and waterproofing/preservative compositions
|
|
AU7661594A
(en)
|
1993-09-22 |
1995-04-10 |
Glaxo Wellcome House |
Bis(amidinobenzimidazolyl)alkanes as antiviral agents
|
|
DE4341161A1
(de)
|
1993-12-02 |
1995-06-08 |
Michael Prof Dr Zeppezauer |
Membrangängiger Wirkstoff zur Störung der DNA-Biosynthese
|
|
JPH07242544A
(ja)
|
1994-03-01 |
1995-09-19 |
Takeda Chem Ind Ltd |
抗腫瘍剤
|
|
CA2246162C
(en)
|
1996-01-23 |
2000-04-04 |
Icn Pharmaceuticals, Inc. |
Modulation of th1/th2 cytokine expression by ribavirin.rtm. and ribavirin.rtm. analogs in activated t-lymphocytes
|
|
HUP0001186A3
(en)
|
1996-10-16 |
2002-04-29 |
Icn Pharmaceuticals Inc Costa |
Purine l-nucleosides,analogs and pharmaceutical compositions thereof
|
|
CN1268140A
(zh)
|
1996-10-16 |
2000-09-27 |
Icn药品公司 |
单环l－核苷、类似物及其应用
|
|
DE69829760T3
(de)
|
1997-09-12 |
2016-04-14 |
Exiqon A/S |
Bi- und tri-zyklische - nukleosid, nukleotid und oligonukleotid-analoga
|
|
AU2787199A
(en)
|
1998-02-25 |
1999-09-15 |
Emory University |
2'-fluoronucleosides
|
|
US20030203862A1
(en)
|
1998-03-26 |
2003-10-30 |
Miraglia Loren J. |
Antisense modulation of MDM2 expression
|
|
WO1999061583A2
(en)
|
1998-05-28 |
1999-12-02 |
Incara Pharmaceuticals Corp. |
Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction
|
|
DE19855963A1
(de)
|
1998-12-04 |
2000-06-08 |
Herbert Schott |
Amphiphile Glycerylnucleotide, Verfahren zu ihrer Herstellung und ihre Verwendung
|
|
US6432975B1
(en)
|
1998-12-11 |
2002-08-13 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
AU776362B2
(en)
|
1999-05-04 |
2004-09-09 |
Roche Innovation Center Copenhagen A/S |
L-ribo-LNA analogues
|
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
JP5230052B2
(ja)
|
2000-05-26 |
2013-07-10 |
イデニクス（ケイマン）リミテツド |
フラビウイルスおよびペスチウイルス治療のための方法および組成物
|
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
|
GB0019124D0
(en)
|
2000-08-03 |
2000-09-27 |
Pfizer |
Novel process
|
|
ATE491459T1
(de)
|
2000-10-18 |
2011-01-15 |
Pharmasset Inc |
Modifizierte nukleoside zur behandlung von virusinfektionen und abnormaler zellulärer proliferation
|
|
US8481712B2
(en)
|
2001-01-22 |
2013-07-09 |
Merck Sharp & Dohme Corp. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
DZ3487A1
(fr)
|
2001-01-22 |
2002-07-25 |
Merck Sharp & Dohme |
Derives de nucleoside comme inhibiteurs de l'arn polymerase virale d'arn-dependant
|
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
|
US6962991B2
(en)
|
2001-09-12 |
2005-11-08 |
Epoch Biosciences, Inc. |
Process for the synthesis of pyrazolopyrimidines
|
|
WO2003026589A2
(en)
|
2001-09-28 |
2003-04-03 |
Idenix (Cayman) Limited |
Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
|
|
US20040006002A1
(en)
|
2001-09-28 |
2004-01-08 |
Jean-Pierre Sommadossi |
Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside
|
|
AU2002351077A1
(en)
|
2001-11-05 |
2003-05-19 |
Exiqon A/S |
Oligonucleotides modified with novel alpha-l-rna analogues
|
|
AT411065B
(de)
|
2001-12-27 |
2003-09-25 |
Dsm Fine Chem Austria Gmbh |
Verfahren zur herstellung von heterocyclischen (r)- und (s)-cyanhydrinen
|
|
US7323453B2
(en)
|
2002-02-13 |
2008-01-29 |
Merck & Co., Inc. |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
|
|
US20120041184A1
(en)
|
2002-02-20 |
2012-02-16 |
Leonid Beigelman |
RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
US20040023901A1
(en)
|
2002-02-28 |
2004-02-05 |
Cook Phillip D. |
Nucleoside 5'-monophosphate mimics and their prodrugs
|
|
WO2003099840A1
(en)
|
2002-05-24 |
2003-12-04 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
|
EP1572945A2
(en)
|
2002-06-27 |
2005-09-14 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
|
TW200500375A
(en)
|
2002-06-28 |
2005-01-01 |
Idenix Cayman Ltd |
Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae
|
|
WO2004007512A2
(en)
|
2002-07-16 |
2004-01-22 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
WO2004014312A2
(en)
|
2002-08-08 |
2004-02-19 |
Sirna Therapeutics, Inc. |
Small-mer compositions and methods of use
|
|
WO2004037159A2
(en)
|
2002-10-23 |
2004-05-06 |
Obetherapy Biotechnology |
Compounds, compositions and methods for modulating fat metabolism
|
|
US7393954B2
(en)
|
2002-12-12 |
2008-07-01 |
Reliable Biopharmaceutical Corporation |
Process for the production of pentostatin aglycone and pentostatin
|
|
WO2004080466A1
(en)
|
2003-03-07 |
2004-09-23 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
|
WO2004091499A2
(en)
|
2003-04-09 |
2004-10-28 |
Neose Technologies, Inc. |
Intracellular formation of peptide conjugates
|
|
CA2522522A1
(en)
|
2003-04-16 |
2004-10-28 |
F. Hoffmann-La Roche Ag |
Quinazoline compounds
|
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
|
WO2005020884A2
(en)
|
2003-05-14 |
2005-03-10 |
Idenix (Cayman) Limited |
Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
|
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
|
CN100503628C
(zh)
|
2003-05-30 |
2009-06-24 |
法莫赛特股份有限公司 |
修饰的氟化核苷类似物
|
|
EP1644479A4
(en)
|
2003-06-16 |
2008-04-23 |
Mark W Grinstaff |
MACROMOLECULES AND FUNCTIONAL SYNTHETIC MOLECULES FOR GENES ADMINISTRATION
|
|
CN1852915A
(zh)
|
2003-07-25 |
2006-10-25 |
艾登尼科斯（开曼）有限公司 |
治疗包括丙型肝炎的黄病毒科病毒所致疾病的嘌呤核苷类似物
|
|
WO2005021568A2
(en)
|
2003-08-27 |
2005-03-10 |
Biota, Inc. |
Novel tricyclic nucleosides or nucleotides as therapeutic agents
|
|
WO2005034878A2
(en)
|
2003-10-08 |
2005-04-21 |
President And Fellows Of Harvard College |
Pyrovalerone analogs and therapeutic uses thereof
|
|
AU2005256963A1
(en)
|
2004-06-23 |
2006-01-05 |
Centre National De La Recherche Scientifique |
5-aza-7-deazapurine derivatives for treating infections with flaviviridae
|
|
JP5080973B2
(ja)
|
2004-06-24 |
2012-11-21 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Ｒｎａ依存性ｒｎａウイルスの感染を処置するためのヌクレオシドアリールホスホルアミダート
|
|
WO2006063717A2
(en)
|
2004-12-16 |
2006-06-22 |
Febit Biotech Gmbh |
Polymerase-independent analysis of the sequence of polynucleotides
|
|
US8802840B2
(en)
|
2005-03-08 |
2014-08-12 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
|
CA2600359A1
(en)
|
2005-03-09 |
2006-09-09 |
Idenix (Cayman) Limited |
Nucleosides with non-natural bases as anti-viral agents
|
|
US7250416B2
(en)
|
2005-03-11 |
2007-07-31 |
Supergen, Inc. |
Azacytosine analogs and derivatives
|
|
WO2006105440A2
(en)
|
2005-03-30 |
2006-10-05 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
|
CA2609342A1
(en)
|
2005-04-26 |
2006-11-02 |
Andrei L. Gartel |
Nucleoside compounds and methods of use thereof
|
|
CN101287472B
(zh)
|
2005-08-15 |
2011-10-12 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒的4'-取代前核苷酸的氨基磷酸酯类化合物
|
|
EP2010553A1
(en)
|
2006-04-03 |
2009-01-07 |
AstraZeneca AB |
Substituted adenines and the uses thereof
|
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
|
HRP20110193T1
(hr)
|
2006-10-10 |
2011-05-31 |
Medivir Ab |
Inhibitor hcv nukleozida
|
|
US20120135091A1
(en)
|
2007-01-18 |
2012-05-31 |
Roth Mark B |
Methods and compositions for enhancing lifespan involving sirtuin-modulating compounds and chalcogenides
|
|
JP2010518015A
(ja)
|
2007-01-31 |
2010-05-27 |
アリオス バイオファーマ インク． |
２−５ａアナログ類およびそれらの使用方法
|
|
JP2008214305A
(ja)
|
2007-03-07 |
2008-09-18 |
Kotobuki Seiyaku Kk |
置換アミン誘導体及びこれを有効成分とする医薬組成物
|
|
WO2008117047A1
(en)
|
2007-03-27 |
2008-10-02 |
Astrazeneca Ab |
Pyrazolo[3, 4-d]pyrimidine derivatives as antibacterial compounds
|
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
WO2008127613A1
(en)
|
2007-04-11 |
2008-10-23 |
Scynexis, Inc. |
New pharmaceutical compositions
|
|
EP1980568A1
(de)
|
2007-04-13 |
2008-10-15 |
Eberhard Karls Universität Tübingen |
Ethinylierte Heterodinucleosidphosphatanaloga, Verfahren zu deren Herstellung und deren Verwendung
|
|
SI2014771T1
(sl)
|
2007-06-25 |
2015-04-30 |
Anadys Pharmaceuticals, Inc. |
Kontinuiran postopek encimske hidrolize
|
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
|
EP2019100A1
(en)
|
2007-07-19 |
2009-01-28 |
Santhera Pharmaceuticals (Schweiz) AG |
Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
|
|
US20090076062A1
(en)
|
2007-09-13 |
2009-03-19 |
Juergen Klaus Maibaum |
Organic Compounds
|
|
GB0718575D0
(en)
|
2007-09-24 |
2007-10-31 |
Angeletti P Ist Richerche Bio |
Nucleoside derivatives as inhibitors of viral polymerases
|
|
WO2009058800A2
(en)
|
2007-10-29 |
2009-05-07 |
President And Fellows Of Harvard College |
Synthesis of nucleosides
|
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
|
US8293720B2
(en)
|
2007-12-20 |
2012-10-23 |
Dogwood Pharmaceuticals, Inc. |
Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
|
US20090176732A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma Inc. |
Protected nucleotide analogs
|
|
WO2009086201A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma, Inc. |
2-5a analogs and their use as anti-cancer, anti-viral and anti- paras iti c agents
|
|
BRPI0908849A2
(pt)
|
2008-02-22 |
2015-08-25 |
Irm Llc |
Composto e composições como c-kit e inibidores de pdgfr quinase
|
|
WO2009129120A2
(en)
|
2008-04-15 |
2009-10-22 |
Rfs Pharma, Llc |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
EP2313102A2
(en)
|
2008-07-03 |
2011-04-27 |
Biota Scientific Management |
Bycyclic nucleosides and nucleotides as therapeutic agents
|
|
GB0815968D0
(en)
|
2008-09-03 |
2008-10-08 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
|
CN102216316A
(zh)
|
2008-09-05 |
2011-10-12 |
寿制药株式会社 |
取代胺衍生物及以其为有效成分的药物组合物
|
|
AR073603A1
(es)
|
2008-09-18 |
2010-11-17 |
Ortho Mcneil Janssen Pharm |
Combinaciones sinergicas de un inhibidor macrociclico del vhc y un nucleosido
|
|
US8551973B2
(en)
|
2008-12-23 |
2013-10-08 |
Gilead Pharmasset Llc |
Nucleoside analogs
|
|
CA2748057C
(en)
|
2008-12-23 |
2018-07-03 |
Pharmasset, Inc. |
Nucleoside phosphoramidates
|
|
EP2376515A1
(en)
|
2008-12-23 |
2011-10-19 |
Pharmasset, Inc. |
Synthesis of purine nucleosides
|
|
GB0900914D0
(en)
|
2009-01-20 |
2009-03-04 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
|
KR101774429B1
(ko)
|
2009-02-06 |
2017-09-04 |
코크리스탈 파마, 아이엔씨. |
암 및 바이러스 감염 치료용 퓨린 뉴클레오시드 모노포스페이트 프로드럭
|
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
|
WO2010108135A1
(en)
|
2009-03-20 |
2010-09-23 |
Alios Biopharma, Inc. |
Protected nucleotide analogs
|
|
MX2011009728A
(es)
|
2009-03-20 |
2011-10-14 |
Alios Biopharma Inc |
Analogos nucleotido y nucleosido sustituidos.
|
|
TWI598358B
(zh)
|
2009-05-20 |
2017-09-11 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
EP2264169A1
(en)
|
2009-06-15 |
2010-12-22 |
Qiagen GmbH |
Modified siNA
|
|
WO2011005595A2
(en)
|
2009-06-24 |
2011-01-13 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
|
WO2011005860A2
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
5' phosphate mimics
|
|
TW201111378A
(en)
|
2009-09-11 |
2011-04-01 |
Bayer Schering Pharma Ag |
Substituted (heteroarylmethyl) thiohydantoins
|
|
BR112012007122A2
(pt)
*
|
2009-09-29 |
2016-07-12 |
Janssen Products Lp |
derivados de fosforamidatos de nucleosídeos
|
|
US20150018301A1
(en)
|
2009-11-06 |
2015-01-15 |
The Johns Hopkins University |
LRRK-2-Mediated Neuronal Toxicity
|
|
CA2794018C
(en)
|
2010-03-24 |
2016-05-10 |
Medical University Of South Carolina |
Compositions and methods for the treatment of degenerative diseases
|
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
|
FR2960235B1
(fr)
|
2010-05-18 |
2013-11-01 |
Inst Francais Du Petrole |
Procede d'oligomerisation des olefines utilisant une composition comprenant un complexe organometallique contenant un ligand alcoxy fonctionnalise par un hetero-atome.
|
|
FR2960234B1
(fr)
|
2010-05-18 |
2013-11-01 |
Inst Francais Du Petrole |
Procede de dimerisation de l'ethylene en butene-1 utilisant une composition comprenant un complexe a base de titane et un ligand alcoxy fonctionnalise par un hetero-atome.
|
|
WO2012012465A1
(en)
|
2010-07-19 |
2012-01-26 |
Clarke, Michael, O'neil Hanrahan |
Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
|
|
PH12013500035A1
(en)
|
2010-07-22 |
2013-03-11 |
Gilead Sciences Inc |
Methods and compounds for treating paramyxoviridae virus infections
|
|
WO2012016713A1
(en)
|
2010-08-05 |
2012-02-09 |
Ruprecht-Karls-Universität Heidelberg |
Tumour targeting with polypeptides
|
|
WO2012025857A1
(en)
|
2010-08-23 |
2012-03-01 |
Hetero Research Foundation |
Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors
|
|
TW201305185A
(zh)
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
用於抗病毒治療之２’－氟取代之碳－核苷類似物
|
|
AU2011305652B2
(en)
|
2010-09-22 |
2016-10-20 |
Janssen Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
|
EA025341B1
(ru)
|
2010-09-22 |
2016-12-30 |
Алиос Биофарма, Инк. |
Замещенные аналоги нуклеотидов
|
|
WO2012040126A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
|
AR083221A1
(es)
|
2010-09-29 |
2013-02-06 |
Univ Nac Quilmes |
Proceso para producir dialquilfosfotriesteres de nucleosidos mediante transesterificacion enzimatica y desproteccion de los mismos para producir nucleosidos monofosfato
|
|
US20120082795A1
(en)
|
2010-10-01 |
2012-04-05 |
Ppg Industries Ohio, Inc. |
Method for using a primer comprising a self-emulsified polyester microgel
|
|
WO2012074547A2
(en)
|
2010-11-29 |
2012-06-07 |
New York University |
STEROID COMPOUNDS AS RORγt MODULATORS AND USES THEREOF
|
|
EP2655392B1
(en)
|
2010-12-22 |
2018-04-18 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
|
WO2012094248A1
(en)
|
2011-01-03 |
2012-07-12 |
Nanjing Molecular Research, Inc. |
O-(substituted benzyl) phosphoramidate compounds and therapeutic use
|
|
WO2012099630A1
(en)
|
2011-01-20 |
2012-07-26 |
University Of Rochester |
Compositions and methods for treating or preventing a retrovirus infection
|
|
WO2012161799A1
(en)
|
2011-02-24 |
2012-11-29 |
Georgia Health Sciences University Research Institute, Inc |
Epidithiodioxopiperazines and uses thereof in treating cancer
|
|
WO2012142523A2
(en)
|
2011-04-13 |
2012-10-18 |
Gilead Sciences, Inc. |
1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment
|
|
EA201391519A1
(ru)
|
2011-04-13 |
2014-03-31 |
Мерк Шарп И Доум Корп. |
2'-замещенные нуклеозидные производные и способы их применения для лечения вирусных заболеваний
|
|
WO2012167133A2
(en)
|
2011-06-01 |
2012-12-06 |
The Regents Of The University Of California |
Inhibitors of anandamide transport and their therapeutic uses
|
|
FR2977586B1
(fr)
|
2011-07-08 |
2013-07-12 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
|
DE102011108874A1
(de)
|
2011-07-28 |
2013-01-31 |
Hydac System Gmbh |
Steuervorrichtung
|
|
WO2013019874A1
(en)
|
2011-08-01 |
2013-02-07 |
Mbc Pharma, Inc. |
Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
|
|
WO2013044030A1
(en)
*
|
2011-09-23 |
2013-03-28 |
Enanta Pharmaceuticals, Inc. |
2'-chloroacetylenyl substituted nucleoside derivatives
|
|
CN103102345B
(zh)
|
2011-11-14 |
2015-06-03 |
广东东阳光药业有限公司 |
氨基喹唑啉类衍生物及其盐和使用方法
|
|
FR2982858B1
(fr)
|
2011-11-18 |
2013-11-29 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
|
FR2984322B1
(fr)
|
2011-12-16 |
2013-12-20 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
|
EA024297B1
(ru)
*
|
2011-12-20 |
2016-09-30 |
Рибосайенс Ллк |
2',4'-дифтор-2'-метилзамещенные нуклеозидные производные в качестве ингибиторов репликации рнк вируса гепатита с
|
|
US8980865B2
(en)
|
2011-12-22 |
2015-03-17 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
|
SG10201610936RA
(en)
|
2011-12-22 |
2017-02-27 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
|
WO2013138210A1
(en)
|
2012-03-14 |
2013-09-19 |
Ning Xi |
Substituted cyclic compounds and methods of use
|
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
EP2828278A4
(en)
|
2012-03-21 |
2015-12-09 |
Alios Biopharma Inc |
PROCESSES FOR PREPARING SUBSTITUTED NUCLEOTIDE ANALOGS
|
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
US8916538B2
(en)
|
2012-03-21 |
2014-12-23 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
|
CN104203253A
(zh)
|
2012-03-21 |
2014-12-10 |
艾丽奥斯生物制药有限公司 |
取代的核苷、核苷酸及其类似物
|
|
WO2013142159A1
(en)
|
2012-03-21 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
|
HK1203356A1
(en)
|
2012-03-22 |
2015-10-30 |
艾丽奥斯生物制药有限公司 |
Pharmaceutical combinations comprising a thionucleotide analog
|
|
GEP20176800B
(en)
|
2012-05-22 |
2018-01-10 |
Idenix Pharmaceuticals Llk |
D-amino acid compounds for liver disease
|
|
EP2676987A1
(en)
|
2012-06-21 |
2013-12-25 |
Universidad De Burgos |
Cross-linked aramid
|
|
CN104583224A
(zh)
|
2012-07-03 |
2015-04-29 |
百时美施贵宝公司 |
制备用于治疗病毒感染的核苷化合物的富含非对映体的氨基磷酸酯衍生物的方法
|
|
HK1211589A1
(zh)
|
2012-08-23 |
2016-05-27 |
Alios Biopharma, Inc. |
用於治疗副粘病毒病毒性感染的化合物
|
|
WO2014047117A1
(en)
|
2012-09-18 |
2014-03-27 |
Bristol-Myers Squibb Company |
Process for preparing phosphoramidate derivatives of nucleoside compounds for treatment of viral infections
|
|
AU2013324681B2
(en)
|
2012-09-26 |
2017-08-10 |
Merck Patent Gmbh |
Quinazolinone derivatives as PARP inhibitors
|
|
JP6666147B2
(ja)
|
2012-09-26 |
2020-03-13 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
環状エーテルピラゾール−４−イル−ヘテロシクリル−カルボキサミド化合物と使用方法
|
|
RU2015119999A
(ru)
|
2012-10-29 |
2016-12-20 |
Кокристал Фарма, Инк. |
Пиримидиновые нуклеозиды и их монофосфатные пролекарства для лечения вырусных инфекций и рака
|
|
US9211300B2
(en)
*
|
2012-12-19 |
2015-12-15 |
Idenix Pharmaceuticals Llc |
4′-fluoro nucleosides for the treatment of HCV
|
|
HK1217325A1
(zh)
|
2012-12-20 |
2017-01-06 |
奥尔德拉医疗公司 |
迫位原醇
|
|
KR20150100814A
(ko)
|
2012-12-21 |
2015-09-02 |
콴티셀 파마슈티컬스, 인크. |
히스톤 데메틸라제 억제제
|
|
CN110684067A
(zh)
*
|
2012-12-21 |
2020-01-14 |
艾丽奥斯生物制药有限公司 |
取代的核苷和核苷酸
|
|
PL2935222T3
(pl)
|
2012-12-21 |
2019-02-28 |
Epizyme Inc |
Inhibitory PRMT5 i ich zastosowania
|
|
SG10201705097PA
(en)
|
2012-12-21 |
2017-07-28 |
Sanofi Sa |
Functionalized exendin-4 derivatives
|
|
UA111305C2
(uk)
|
2012-12-21 |
2016-04-11 |
Пфайзер Інк. |
Конденсовані лактами арилу та гетероарилу
|
|
US9233974B2
(en)
|
2012-12-21 |
2016-01-12 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
WO2014100498A1
(en)
|
2012-12-21 |
2014-06-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
EA026687B1
(ru)
|
2012-12-21 |
2017-05-31 |
Ф. Хоффманн-Ля Рош Аг |
Пептиды в качестве агонистов окситоцина
|
|
FR3000065A1
(fr)
|
2012-12-21 |
2014-06-27 |
Univ Lille Ii Droit & Sante |
Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes
|
|
KR102212923B1
(ko)
|
2012-12-21 |
2021-02-04 |
플렉시콘 인코퍼레이티드 |
키나제 조절을 위한 화합물 및 방법, 및 그에 대한 적응증
|
|
LU92126B1
(fr)
|
2012-12-31 |
2014-07-01 |
Cesa Alliance Sa |
Composé pharmaceutique pour la prévention et le traitement d'un trouble ou d'une maladie de la mémoire, neurodégénérative ou neuronale
|
|
WO2014134251A1
(en)
|
2013-02-28 |
2014-09-04 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
|
ES2616508T3
(es)
*
|
2013-03-04 |
2017-06-13 |
Bayer Cropscience Aktiengesellschaft |
Derivados de 1H-pirazol sustituidos con halógeno como insecticidas
|
|
WO2014164533A1
(en)
|
2013-03-11 |
2014-10-09 |
Vertex Pharmaceuticals Incorporated |
Methods of stereoselective synthesis of substituted nucleoside analogs
|
|
WO2014165704A1
(en)
|
2013-04-05 |
2014-10-09 |
Vertex Pharmaceuticals, Inc. |
Hepatitis c viral infection treatment using a combination of compounds
|
|
MY186547A
(en)
|
2013-05-16 |
2021-07-26 |
Riboscience Llc |
4?-fluoro-2?-methyl substituted nucleoside derivatives
|
|
US9815864B2
(en)
|
2013-06-26 |
2017-11-14 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
EP3424938B1
(en)
|
2013-06-26 |
2020-07-22 |
Janssen BioPharma, Inc. |
4'-azidoalkyl-substituted nucleosides, nucleotides and analogs thereof
|
|
HK1225716A1
(zh)
|
2013-08-21 |
2017-09-15 |
Alios Biopharma, Inc. |
抗病毒化合物
|
|
AU2014318832B2
(en)
|
2013-09-12 |
2018-11-29 |
Janssen Biopharma, Inc. |
Aza-pyridone compounds and uses thereof
|
|
CN105722831B
(zh)
|
2013-09-12 |
2019-08-06 |
艾丽奥斯生物制药有限公司 |
哒嗪酮化合物及其用途
|
|
AU2014331863C1
(en)
*
|
2013-10-11 |
2019-05-16 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
CN117379452A
(zh)
*
|
2014-06-24 |
2024-01-12 |
艾丽奥斯生物制药有限公司 |
取代的核苷、核苷酸和其类似物
|
|
AU2015280234B2
(en)
|
2014-06-24 |
2021-04-01 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
CA2955604A1
(en)
|
2014-07-22 |
2016-01-28 |
Alios Biopharma, Inc. |
Methods for treating paramyxoviruses
|
|
EP3177299A4
(en)
|
2014-08-05 |
2018-04-04 |
Alios Biopharma, Inc. |
Combination therapy for treating a paramyxovirus
|
|
US9908914B2
(en)
|
2014-10-28 |
2018-03-06 |
Alios Biopharma, Inc. |
Methods of preparing substituted nucleoside analogs
|
|
MA41213A
(fr)
|
2014-12-19 |
2017-10-24 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
|
MA41614A
(fr)
|
2015-02-25 |
2018-01-02 |
Alios Biopharma Inc |
Composés antiviraux
|
|
MX383931B
(es)
|
2015-03-11 |
2025-03-14 |
Janssen Biopharma Inc |
Compuestos de aza-piridona y usos de estos.
|
|
JP6860585B2
(ja)
|
2016-03-09 |
2021-04-14 |
ヤンセン バイオファーマ インク． |
非環状抗ウイルス 優先出願の参照による組み込み
|
|
US10183945B2
(en)
|
2016-03-10 |
2019-01-22 |
Alios Biopharma, Inc. |
Method of preparing AZA-pyridone compounds
|
|
WO2017223231A1
(en)
|
2016-06-21 |
2017-12-28 |
Alios Biopharma, Inc. |
(s)-8-(benzhydryl )-6-isopropyl-3,5-dioxo- 5, 6,7,8,-tetrahydro-3h-pyrazino-[1,2-b]pyridazin-yl-isobutyrate antiviral agent for use in treating influenza
|
|
US20180117042A1
(en)
|
2016-10-27 |
2018-05-03 |
Alios Biopharma, Inc. |
Methods for treating respiratory syncytial virus infection
|
|
WO2018222774A1
(en)
|
2017-05-30 |
2018-12-06 |
Alios Biopharma, Inc. |
Methods for treating pneumoviruses
|
|
MX2021006993A
(es)
|
2018-12-12 |
2021-10-22 |
Janssen Biopharma Inc |
Analogos de nucleosidos de ciclopentilo como antivirales.
|
|
US20220048912A1
(en)
|
2018-12-12 |
2022-02-17 |
Janssen Biopharma, Inc. |
Cyclobutyl nucleoside analogs as anti-virals
|